Arsenal Capital Partners has announced it acquired BresMed Health Solutions.
BresMed, with its U.S. office in Las Vegas, Nev., is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry.
Arsenal, based in New York, is a private equity firm specializing in investments in middle market healthcare and specialty industrials companies. Founded in 2000, the firm seeks control investments in companies with the capacity to use $50 million to $300 million of equity, including add-on acquisitions.
Terms of the transaction were not disclosed.